APOE ε4 与路易体病理严重程度相关且独立于阿尔茨海默病理
本研究对652例尸检确诊的路易体病(LBD)病例和660例临床对照进行APOE基因分型,并按路易体病理和阿尔茨海默病(AD)病理严重程度分组,分析APOE ε4与不同神经病理亚组风险的关系。结果发现ε4与低AD病理的弥漫性LBD风险增加相关(OR=3.46,p=0.001),且与5个皮层区域路易体计数增多独立相关,提示ε4可能作为路易体扩散过程的修饰因素而非直接启动因素。
要点
- APOE ε4与低AD病理的弥漫性LBD风险增加相关(OR=3.46,p=0.001)。
- 在低AD病理LBD亚组中,ε4与5个皮层区域路易体计数显著增多独立相关(所有p≤0.002)。
- ε4与中或高AD病理的移行型和弥漫性LBD风险增加相关(所有OR≥3.42,所有p≤0.004)。
核心结论
- APOE ε4独立地与更严重的路易体病理相关。
- 这些发现提示ε4可能作为促进路易体扩散过程的修饰因素,而非直接启动路易体病理。
研究设计与样本
- 研究纳入652例尸检确诊的路易体病(LBD)病例和660例临床对照,对APOE进行基因分型。
- 在病例对照分析中,LBD病例根据路易体病理(脑干、移行、弥漫)和AD病理(低、中、高)严重程度分为9个亚组,评估APOE ε4与不同神经病理定义LBD亚组风险的关系。
- 在仅LBD病例中,测量5个皮层区域的路易体计数,并根据AD病理严重程度评估与ε4的关联。
主要发现
- APOE ε4与中或高AD病理病例的移行型和弥漫性LBD风险增加相关(所有OR≥3.42,所有p≤0.004)。
- ε4与低AD病理的弥漫性LBD风险增加相关(OR=3.46,p=0.001)。
- 在低AD病理LBD亚组中,ε4与5个皮层区域的路易体计数显著增多独立相关(所有p≤0.002)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate whether APOE ε4 is associated with severity of Lewy body (LB) pathology, independently of Alzheimer disease (AD) pathology. METHODS: Six hundred fifty-two autopsy-confirmed LB disease (LBD) cases and 660 clinical controls were genotyped for APOE. In case-control analysis, LBD cases were classified into 9 different groups according to severity of both LB pathology (brainstem, transitional, diffuse) and AD pathology (low, moderate, high) to assess associations between APOE ε4 and risk of different neuropathologically defined LBD subgroups in comparison to controls. In LBD cases only, we also measured LB counts from 5 cortical regions and evaluated associations with ε4 according to severity of AD pathology. RESULTS: As expected, APOE ε4 was associated with an increased risk of transitional and diffuse LBD in cases with moderate or high AD pathology (all odds ratios ≥3.42, all p ≤ 0.004). Of note, ε4 was also associated with an increased risk of diffuse LBD with low AD pathology (odds ratio = 3.46, p = 0.001). In the low AD pathology LBD subgroup, ε4 was associated with significantly more LB counts in the 5 cortical regions, independently of Braak stage and Thal phase (all p ≤ 0.002). CONCLUSIONS: Our results indicate that APOE ε4 is independently associated with a greater severity of LB pathology. These findings increase our understanding of the mechanism behind reported associations of ε4 with risk of dementia with Lewy bodies and Parkinson disease with dementia, and suggest that ε4 may function as a modifier of processes that favor LB spread rather than acting directly to initiate LB pathology.
引用
- Dickson DW, Heckman MG, Murray ME, et al. APOE ε4 is associated with severity of Lewy body pathology independent of Alzheimer pathology. Neurology. 2018. PMID: 30143564. doi:10.1212/WNL.0000000000006212
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。